Contract facts
SBANo full NAICS 622110 intel page yet. Browse NAICS intelligence
CLINICAL PHARMACIST- FINAL DEOBLIGATION MOD is a federal SBA award for Fa4460 19 Cons Pka held by Aliron International, Inc. Estimated value $518K ($-22,637.2 obligated). Current period of performance ends Dec 19, 2021 (potential Jun 19, 2024). Last award drew 24 bidders. Place of performance: LITTLE ROCK AFB AR.
CLINICAL PHARMACIST- FINAL DEOBLIGATION MOD
Recompete timing
PublicCurrent PoP ended Dec 19, 2021 (1706 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract FA446019FA022?
FA446019FA022 (Clinical pharmacist- FINAL deobligation MOD) is a Fa4460 19 Cons Pka award with a potential value of $518K, currently held by Aliron International, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded FA446019FA022?
Fa4460 19 Cons Pka awarded FA446019FA022 to Aliron International, Inc (potential $518K).
Who is the incumbent on FA446019FA022?
Aliron International, Inc is the incumbent. The current period of performance ends Dec 19, 2021.
When does Aliron International, Inc’s FA446019FA022 come up for recompete?
SCOUT tracks a period-of-performance end of Dec 19, 2021. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.